(1)
A New RP- HPLC Method Development and Validation for the Concurrent Identification of Nivolumab and Hyaluronidase in Bulk and Pharmaceutical Dosage Form. AJCPR 2025, 13 (1), 47-52. https://doi.org/10.30904/j.ajcpr.2025.4812.